Study on Surface Esterification of Cellulose Nanocrystals Their and Lipid-Lowering Effect

被引:0
|
作者
Yang, Jiachuan [1 ]
Liu, Jianxia [1 ]
Zhang, Xiaochen [2 ]
机构
[1] Shanxi Datong Univ, Coll Agr & Life Sci, 405 Xingyun St, Datong 037009, Shanxi, Peoples R China
[2] Jilin Vocat & Tech Coll, Longjing, Peoples R China
关键词
Cellulose nanocrystal; esterification modification; fat; digestion; absorption; buckwheat fiber;
D O I
10.1080/15440478.2024.2410937
中图分类号
TB3 [工程材料学]; TS1 [纺织工业、染整工业];
学科分类号
0805 ; 080502 ; 0821 ;
摘要
With the rapid development of the economy and changes in dietary structure, there is an excessive intake of high sugar and high-fat foods. To address this issue, in this study, we grafted palmitic acid onto CNC in the form of ester groups and evaluated its adsorption performance. Research had found that among these three methods, the CDI catalytic method can successfully obtain esterification modified CNC while also taking into account its environmentally friendly and pollution-free characteristics. Compared with CNC, its adsorption capacity for oil had increased, with the maximum adsorption capacity increasing from 35.80 g/g to 46.91 g/g. Meanwhile, the degree of esterification substitution of esterification modified CNC was measured, and the result was 0.03. Especially, after adding CNC-PA, the hydrolysis of fat was significantly reduced during the simulated digestion in vitro, whilst the absorption of fat in the intestine was significantly inhibited. In vivo testing also confirmed that consuming a diet containing CNC-PA significantly reduced elevated levels of triglycerides (TG) compared to the high-fat control group while long-term feeding of a diet containing CNC-PA reduced weight and fat accumulation.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Lipid-Lowering Agents
    Ewang-Emukowhate, Mfon
    Wierzbicki, Anthony S.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 18 (05) : 401 - 411
  • [22] Lipid-lowering drugs
    Andréjak, M
    Caron, J
    Libersa, C
    Thery, C
    THERAPIE, 2003, 58 (01): : 1 - 2
  • [23] LIPID-LOWERING TREATMENTS
    DAIROU, F
    PRESSE MEDICALE, 1987, 16 (26): : 1277 - 1281
  • [24] LIPID-LOWERING DRUGS
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1985, 27 (695): : 74 - 76
  • [25] LIPID-LOWERING DRUGS
    MCLOUGHLIN, I
    CLARKE, P
    BRITISH JOURNAL OF PSYCHIATRY, 1989, 154 : 275 - 276
  • [26] Lipid-lowering drugs
    Pahan, K.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (10) : 1165 - 1178
  • [27] A study of compliance with lipid-lowering therapy in inpatients
    Jaudon, T
    Bruckert, E
    Giral, P
    Turpin, G
    SEMAINE DES HOPITAUX, 1998, 74 (15-16): : 693 - 699
  • [28] THE LIPID-LOWERING EFFECT OF FEBUPROL IN VARIOUS CASES OF HYPERLIPIDEMIA
    PREISCH, P
    FARKAS, IE
    DARVAS, I
    DIGESTIVE DISEASES AND SCIENCES, 1986, 31 (10) : S495 - S495
  • [29] Lipid-Lowering Effect of Nattokinase in Patients with Primary Hypercholesterolemia
    Wu, Der-Jinn
    Lin, Cheng-Sheng
    Lee, Ming-Yung
    ACTA CARDIOLOGICA SINICA, 2009, 25 (01) : 26 - 30
  • [30] Effect of lipid-lowering therapy on vasomotion and endothelial function
    Kinlay S.
    Plutzky J.
    Current Cardiology Reports, 1999, 1 (3) : 238 - 243